A Multi-omics Study of "Healthy" Premature CAD Patients (NCT06362278) | Clinical Trial Compass
UnknownNot Applicable
A Multi-omics Study of "Healthy" Premature CAD Patients
China160 participantsStarted 2024-03-20
Plain-language summary
The goal of this multi-center observational clinical trial is to investigate the genetic risk factors of patients with premature CAD and none traditional CAD risk factors through a multi-omics approach.
The main questions it aims to answer are:
* Genetic risk factors \& metabolic fingerprints of patients with premature CAD and none traditional CAD risk factors remain unknown.
* How to optimize current primary prevention strategy for this rare CAD subgroup？
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. In-patients from cardiology department of either following 3 hospitals: a) The First Affiliated Hospital of Nanjing Medical University; b) Qilu Hospital of Shandong University; c) The Second Affiliated Hospital Zhejiang University School of Medicine
✓. Confirmed diagnosis of Obstructive CAD (≥50% diameter stenosis in a major epicardial vessel) through coronary angiography
✓. Age of the patient when Obstructive CAD was for the first time diagnosed should be no more than 45 years old for the male and 55 years old for the female.
✓. In-patients from cardiology department of either following 3 hospitals: a) The First Affiliated Hospital of Nanjing Medical University; b) Qilu Hospital of Shandong University; c) The Second Affiliated Hospital Zhejiang University School of Medicine
✓. Coronary artery stenosis was ruled out through either coronary angiography or coronary CTA.
Exclusion criteria
✕. Patients with hypertension (grade 1-3)
✕. Patients with type 1 or type 2 diabetes mellitus
✕. BMI \>28.0 Kg/m\^2
✕. Patients with non-ideal blood lipids level on admission(defined as either LDL-C≥2.6mmol/L OR non-HDL cholesterol≥3.4mmol/L OR Lipoprotein(a) ≥300mg/L)
✕. Smoker (Smoking for more than 6 consecutive or cumulative months in a lifetime, whether quit smoking or not)
✕
What they're measuring
1
common & rare variants associated with "healthy" pre-mature CAD phenotype
Timeframe: 3 months
2
Unique metabolomic fingerprints associated with "healthy" pre-mature CAD phenotype
Timeframe: 3 months
Trial details
NCT IDNCT06362278
SponsorThe First Affiliated Hospital with Nanjing Medical University